Top News

Ninth patient dosed in ongoing Phase 1b trial evaluating tegoprubart in patients undergoing kidney transplantation; updated clinical data expected in...

Shockwave Medical Announces Proposed Private Offering of $500.0 Million of Convertible Senior Notes

SANTA CLARA, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV) (“Shockwave Medical”) announced today that it...

Altimmune Announces Second Quarter 2023 Financial Results and Provides a Business Update

Top-line 48-week results from the MOMENTUM Phase 2 obesity trial expected Q4 2023 Commenced enrollment in IMPACT Phase 2b trial...

Applied Therapeutics Reports Second Quarter 2023 Financial Results

Regulatory progress for govorestat (AT-007) for the treatment of Classic Galactosemia, with potential NDA submission based on discussions with the...

Larimar Therapeutics Reports Second Quarter 2023 Operating and Financial Results

Initiation cleared for 50 mg cohort in Phase 2 Friedreich's ataxia (FA) dose exploration trial following FDA review of unblinded...

Innovative Food Holdings, Inc. Reports Financial Results for Second Quarter of 2023

Key highlights: Second quarter adjusted EBITDA improved by $1.2 million to $453,947, first profitable second quarter since 2019Second quarter revenue...

OTC Markets Group Welcomes Li-FT Power Ltd. to OTCQX

NEW YORK, Aug. 10, 2023 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading...

Entrada Therapeutics Appoints Gina Chapman to its Board of Directors

Ms. Gina Chapman Ms. Gina Chapman BOSTON, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA), a biopharmaceutical...

Immunovant Reports Financial Results and Provides Corporate Updates for the Quarter Ended June 30, 2023